Search Results - "Gwo, Jennifer"

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    First‐in‐human phase 1 study of MK‐1248, an anti–glucocorticoid‐induced tumor necrosis factor receptor agonist monoclonal antibody, as monotherapy or with pembrolizumab in patients with advanced solid tumors

    First‐in‐human phase 1 study of MK‐1248, an anti–glucocorticoid‐induced tumor necrosis factor receptor agonist monoclonal antibody, as monotherapy or with pembrolizumab in patients with advanced solid tumors by Geva, Ravit, Voskoboynik, Mark, Dobrenkov, Konstantin, Mayawala, Kapil, Gwo, Jennifer, Wnek, Richard, Chartash, Elliot, Long, Georgina V.

    Published in Cancer (15-11-2020)
    “…Background Ligation of glucocorticoid‐induced tumor necrosis factor receptor (GITR) decreases regulatory T cell–mediated suppression and enhances T‐cell…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    First-in-human phase 1 study of MK-1248, an anti-human glucocorticoid-induced tumor necrosis factor receptor (GITR) monoclonal antibody, as monotherapy or in combination with pembrolizumab in patients with advanced solid tumors

    First-in-human phase 1 study of MK-1248, an anti-human glucocorticoid-induced tumor necrosis factor receptor (GITR) monoclonal antibody, as monotherapy or in combination with pembrolizumab in patients with advanced solid tumors by Geva, Ravit, Voskoboynik, Mark, Beebe, Amy M, Gwo, Jennifer, Dobrenkov, Konstantin, Chartash, Elliot, Long, Georgina V.

    Published in Journal of clinical oncology (20-05-2018)
    “…Abstract only…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: